During the last session, Telomir Pharmaceuticals Inc (NASDAQ:TELO)’s traded shares were 0.53 million. At the end of the trading day, the stock’s price was $5.20, reflecting an intraday gain of 2.16% or $0.11. The 52-week high for the TELO share is $20.72, that puts it down -298.46 from that peak though still a striking 40.19% gain since the share price plummeted to a 52-week low of $3.11. The company’s market capitalization is $153.97M, and the average intraday trading volume over the past 10 days was 0.27 million shares, and the average trade volume was 157.46K shares over the past three months.

Telomir Pharmaceuticals Inc (NASDAQ:TELO) trade information

Telomir Pharmaceuticals Inc (TELO) registered a 2.16% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 2.16% in intraday trading to $5.20, hitting a weekly high. The stock’s 5-day price performance is -20.25%, and it has moved by 30.65% in 30 days. The short interest in Telomir Pharmaceuticals Inc (NASDAQ:TELO) is 0.65 million shares and it means that shorts have 5.77 day(s) to cover.

Telomir Pharmaceuticals Inc (TELO) estimates and forecasts

Statistics show that Telomir Pharmaceuticals Inc has underperformed its competitors in share price, compared to the industry in which it operates. Telomir Pharmaceuticals Inc (TELO) shares have gone down -5.45% during the last six months, with a year-to-date growth rate less than the industry average at -20.00% against 16.40.

TELO Dividends

Telomir Pharmaceuticals Inc is due to release its next quarterly earnings in January. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.